Skip to content
OpenCapital
Get started

HCW Biologics HCWB Q1 2026 Annual earnings

Reported May 14, 2026 · Before market open

Revenue$6.5MMiss by $11.1K
EPS$0.37Beat by $0.81
Revenue estimate$6.5M
EPS estimate-$0.44

Next report

Aug 7, 2026 (In 1 week)
Revenue estimate$5.7M
EPS estimate-$1.98

Versus estimates

Revenue

Q1 2026$6.5MMiss by $11.1K
Q4 2025$5.4MMiss by $1.6MQ3 2025$15.6KMiss by $7.0MQ2 2025$6.6KMiss by $450.0Q1 2025$5.1KQ4 2024$394.8KMiss by $6.6M

Diluted EPS

Q1 2026$0.37Beat by $0.81
Q4 2025-$2.63Miss by $1.79Q3 2025-$2.02Miss by $3.60Q2 2025-$6.79Miss by $8.59Q1 2025-$0.05Q4 2024-$3.20Miss by $6.80

Ask the moment HCW Biologics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did HCW Biologics report Q1 2026 earnings?
HCW Biologics (HCWB) reported Q1 2026 earnings on May 14, 2026 before market open.
What were HCW Biologics's Q1 2026 revenue and EPS?
HCW Biologics reported revenue of $6.5M and eps of $0.37 for Q1 2026.
Did HCW Biologics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $6.5M by $11.1K. EPS beat the consensus estimate of $-0.44 by $0.81.
How did HCW Biologics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 128862.1% from $5.1K a year earlier.
Where can I find HCW Biologics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-023122) and the 10-K periodic report (0001193125-26-134934) directly on SEC EDGAR. The filing index links above go to sec.gov.